High-risk neuroblastoma is designated based on the demonstration of clinically advanced stage or the presence of metastasis, age greater than 18 months at diagnosis, MYCN oncogene amplification, histology, and/or chromosomal ploidy [3]. Here, MYCN is linked to neuroblastoma.